Automation and validation of DNA-banking systems.

DNA banking is one of the central capabilities on which modern genetic research rests. The DNA-banking system plays an essential role in the flow of genetic data from patients and genetics researchers to the application of genetic research in the clinic. Until relatively recently, large collections of DNA samples were not common in human genetics. Now, collections of hundreds of thousands of samples are common in academic institutions and private companies. Automation of DNA banking can dramatically increase throughput, eliminate manual errors and improve the productivity of genetics research. An increased emphasis on pharmacogenetics and personalized medicine has highlighted the need for genetics laboratories to operate within the principles of a recognized quality system such as good laboratory practice (GLP). Automated systems are suitable for such laboratories but require a level of validation that might be unfamiliar to many genetics researchers. In this article, we use the AstraZeneca automated DNA archive and reformatting system (DART) as a case study of how such a system can be successfully developed and validated within the principles of GLP.

[1]  Michael Doherty,et al.  Pharmacogenetics--legal, ethical and regulatory considerations. , 2001, Pharmacogenomics.

[2]  Sophie Visvikis,et al.  DNA Extraction and Stability for Epidemiological Studies , 1998, Clinical chemistry and laboratory medicine.

[3]  Anne Cambon-Thomsen,et al.  An empirical survey on biobanking of human genetic material and data in six EU countries , 2003, European Journal of Human Genetics.

[4]  R. March.  Pharmacogenomics: The Genomics of Drug Response , 2000, Yeast.

[5]  M Heath-Chiozzi,et al.  Clinical application of pharmacogenetics. , 2001, Trends in molecular medicine.

[6]  Sue-Jane Wang,et al.  Pharmacogenomic data submissions to the FDA: clinical case studies. , 2004, Pharmacogenomics.

[7]  M. Alpers,et al.  High-Throughput SNP Genotyping , 2002, Comparative and functional genomics.

[8]  Iris H Xie,et al.  Automated calibration of TECAN genesis liquid handling workstation utilizing an online balance and density meter. , 2004, Assay and drug development technologies.

[9]  Scott Mahan,et al.  Collaborative design for automated DNA storage that allows for rapid, accurate, large-scale studies. , 2004, Assay and drug development technologies.

[10]  R. Waterston,et al.  Low pressure DNA shearing: a method for random DNA sequence analysis. , 1990, Nucleic acids research.

[11]  L. Madisen,et al.  DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. , 1987, American journal of medical genetics.

[12]  S. Ring,et al.  A new human genetic resource: a DNA bank established as part of the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC) , 2000, European Journal of Human Genetics.

[13]  D. H. Farkas,et al.  Specimen Stability for DNA‐based Diagnostic Testing , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[14]  N. Haites,et al.  Repeated freezing and thawing of peripheral blood and DNA in suspension: effects on DNA yield and integrity. , 1990, Journal of medical genetics.

[15]  J. Haines,et al.  Localization of one gene for tuberous sclerosis within 9q32-9q34, and further evidence for heterogeneity. , 1991, American journal of human genetics.

[16]  Eric Sampson,et al.  DNA Banking for Epidemiologic Studies: A Review of Current Practices , 2002, Epidemiology.

[17]  J. Woodcock,et al.  Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective , 2004, Nature Reviews Drug Discovery.

[18]  Neil Gibson,et al.  Novel technology and the development of pharmacogenetics within the pharmaceutical industry. , 2005, Pharmacogenomics.